{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:26:15Z","timestamp":1792034775243,"version":"4.4.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Differentiating primary central nervous system lymphoma (PCNSL) from tumefactive demyelinating lesions (TDLs) remains a major diagnostic challenge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Our study aimed to compare the differences in clinical observations, neuroimaging data, and pathological features between the PCNSL and TDLs, as well as their potential biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This was a retrospective observational cohort study of 183 patients (97 PCNSL and 86 TDLs). Baseline clinical data were collected. Neuroimaging features were determined by MRI. Pathological characteristics were evaluated by using hematoxylin-eosin (HE) staining, and immunochemical staining of CD3 and CD20. Cerebrospinal fluid (CSF) and serum biomarkers were detected by using the commercial protein assay kit and the enzyme-linked immunosorbent assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with PCNSL had an older onset age, with the mean age being 59\u00a0\u00b1\u00a010 years in the PCNSL group and 36\u00a0\u00b1\u00a08 years in the TDL group (p &amp;lt; 0.001). Upon MRI scans, brain lesions in PCNSL showed U-shaped hyperintense, while lesions in TDLs showed slightly diffuse hyperintense on diffusion-weighted imaging (DWI) sequence. PCNSL lesions showed obvious hyperintense and perifocal edema, while TDL lesions showed isointense with partial perifocal edema on fluid attenuated inversion recovery (FLAIR) sequences. CD20 was strongly positive, while CD3 was negative in PCNSL tissues, which was different from a lower CD20 and stronger CD3 levels in TDLs. IL-6 and IL-10 levels was higher in the CSF of PCNSL than TDLs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Careful and comprehensive evaluation of clinical, neuroimaging, and pathological features, and CSF IL-6 and IL-10 levels facilitates the differential diagnosis betweenPCNSL and TDLs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1763680","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:16:50Z","timestamp":1780039010000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Primary central nervous system lymphoma and tumefactive demyelinating lesions in multiple sclerosis: a retrospective observational cohort study"],"prefix":"10.3389","volume":"16","author":[{"given":"Yushan","family":"Chen","sequence":"first","affiliation":[{"name":"Radiology Department, Zhangzhou Affiliated Hospital of Fujian Medical University","place":["Zhangzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lvying","family":"Shen","sequence":"additional","affiliation":[{"name":"Hematology Department, Zhangzhou Affiliated Hospital of Fujian Medical University","place":["Zhangzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunyong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Imaging, Zhangzhou Affiliated Hospital of Fujian Medical University","place":["Zhangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Xie","sequence":"additional","affiliation":[{"name":"Neurosurgery Department, Fujian Zhangzhou Traditional Chinese Medicine Hospital","place":["Zhangzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuishun","family":"Zheng","sequence":"additional","affiliation":[{"name":"Neurosurgery Department, Zhangzhou Affiliated Hospital of Fujian Medical University","place":["Zhangzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.357","article-title":"Age, gender, and racial differences in incidence and survival in primary CNS lymphoma","volume":"105","author":"Villano","year":"2011","journal-title":"Br J Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-010-0457-5","article-title":"Increasing age at diagnosis and worsening renal function in patients with primary central nervous system lymphoma","volume":"104","author":"Bessell","year":"2011","journal-title":"J Neuro-Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2003.01.135","article-title":"Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002","volume":"21","author":"Ferreri","year":"2003","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3606970","article-title":"Primary CNS lymphomas: Challenges in diagnosis and monitoring","volume":"2018","author":"Chiavazza","year":"2018","journal-title":"BioMed Res Int"},{"key":"B5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12883-016-0596-1","article-title":"Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination","volume":"16","author":"Kvarta","year":"2016","journal-title":"BMC Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4302-2548-5_12","article-title":"Tumefactive demyelination: updated perspectives on diagnosis and management","volume":"21","author":"Sanchez","year":"2021","journal-title":"Expert Rev Neurother"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/92.2.103","article-title":"Central nervous system sarcoidosis--diagnosis and management","volume":"92","author":"Zajicek","year":"1999","journal-title":"QJM"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.70.2.259","article-title":"Diagnosis of a multifocal B cell lymphoma with preceding demyelinating central nervous system lesions by single voxel proton MR spectroscopy","volume":"70","author":"Kuhlmann","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1017\/s0317167100012610","article-title":"Inflammatory demyelinating brain lesions heralding primary CNS lymphoma","volume":"39","author":"Husseini","year":"2012","journal-title":"Can J Neurol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2015.3481","article-title":"Cerebral tumefactive demyelinating lesions","volume":"10","author":"Qi","year":"2015","journal-title":"Oncol Lett"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2019.10.010","article-title":"Diagnostic impact of preoperative corticosteroids in primary central nervous system lymphoma","volume":"72","author":"Bullis","year":"2020","journal-title":"J Clin Neurosci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/2055217319855755","article-title":"Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments","volume":"5","author":"Brod","year":"2019","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2011.06.037","article-title":"Open ring enhancement in atypical brain demyelination","volume":"19","author":"Javalkar","year":"2012","journal-title":"J Clin Neurosci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/1352458508097922","article-title":"Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy","volume":"15","author":"Malhotra","year":"2009","journal-title":"Mult Scler"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/rct.0000000000000636","article-title":"Differentiating primary central nervous system lymphomas from glioblastomas and inflammatory demyelinating pseudotumor using relative minimum apparent diffusion coefficients","volume":"41","author":"Wen","year":"2017","journal-title":"J Comput Assist Tomogr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.6026\/973206300220470","article-title":"Comparative histological assessment of p53, Ki-67 and EGFR in oral squamous cell carcinoma grading and prognostication","volume":"22","author":"Nazneen","year":"2026","journal-title":"Bioinformation"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2017.05.014","article-title":"High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma","volume":"59","author":"Dlouhy","year":"2017","journal-title":"Leuk Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500361029","article-title":"Aggressive non-Hodgkin's lymphoma: concomitant evaluation of interleukin-2, soluble interleukin-2 receptor, interleukin-4, interleukin-6, interleukin-10 and correlation with outcome","volume":"47","author":"Fabre-Guillevin","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/1352458510379247","article-title":"Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6","volume":"16","author":"Uzawa","year":"2010","journal-title":"Mult Scler"},{"key":"B20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0165-5728(91)90073-g","article-title":"Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis","volume":"32","author":"Maimone","year":"1991","journal-title":"J Neuroimmunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511424903","article-title":"Cytokine mapping in cerebrospinal fluid and blood in multiple sclerosis patients without oligoclonal bands","volume":"18","author":"Vrethem","year":"2012","journal-title":"Mult Scler"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5045\/br.2017.52.4.285","article-title":"Primary central nervous system lymphoma: a new prognostic model for patients with diffuse large B-cell histology","volume":"52","author":"Ahn","year":"2017","journal-title":"Blood Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08928.x","article-title":"Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system","volume":"156","author":"Baraniskin","year":"2012","journal-title":"Br J Haematol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-019-03208-w","article-title":"Prognostic markers for immunodeficiency-associated primary central nervous system lymphoma","volume":"144","author":"Kaulen","year":"2019","journal-title":"J Neuro-Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2014.08.004","article-title":"Cerebral tumor or pseudotumor","volume":"95","author":"Leclercq","year":"2014","journal-title":"Diagn Interv Imaging"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2021.05.038","article-title":"Neuroinflammation preceding primary central nervous system lymphoma (PCNSL) - Case reports and literature review","volume":"89","author":"Norrington","year":"2021","journal-title":"J Clin Neurosci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/brainsci11020191","article-title":"Inflammatory brain lesions as omen of primary central nervous system lymphoma: a case report and literature review","volume":"11","author":"Kim","year":"2021","journal-title":"Brain Sci"},{"key":"B28","article-title":"Primary central nervous system lymphoma--a report of 32 cases with literature review","volume":"25","author":"Yi","year":"2006","journal-title":"Ai Zheng"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-007-0754-x","article-title":"MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings","volume":"255","author":"Seewann","year":"2008","journal-title":"J Neurol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1107957","article-title":"The value of convolutional neural networks-based deep learning model in differential diagnosis of space-occupying brain diseases","volume":"14","author":"Miao","year":"2023","journal-title":"Front Neurol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2017.72.7602","article-title":"Primary CNS lymphoma","volume":"35","author":"Grommes","year":"2017","journal-title":"J Clin Oncol"},{"key":"B32","article-title":"Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center","volume":"23","author":"Kilic","year":"2013","journal-title":"Turk Neurosurg"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.a1447","article-title":"CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003","volume":"30","author":"Haldorsen","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1148\/radiographics.17.6.9397461","article-title":"Primary central nervous system lymphoma: radiologic-pathologic correlation","volume":"17","author":"Koeller","year":"1997","journal-title":"Radiographics"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s003300101037","article-title":"Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients","volume":"12","author":"Coulon","year":"2002","journal-title":"Eur Radiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/foc.2006.21.5.5","article-title":"Imaging of primary central nervous system lymphoma","volume":"21","author":"Go","year":"2006","journal-title":"Neurosurg Focus"},{"key":"B37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/s0303-8467(02)00105-1","article-title":"Neuroradiological findings in primary cerebral lymphomas of non-AIDS patients","volume":"105","author":"Gliemroth","year":"2003","journal-title":"Clin Neurol Neurosurg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s002340000480","article-title":"Primary central nervous system lymphoma in AIDS: a wider spectrum of CT and MRI findings","volume":"43","author":"Thurnher","year":"2001","journal-title":"Neuroradiology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104992","article-title":"Tumefactive demyelinating lesions versus CNS neoplasms, a comparative study","volume":"79","author":"Chew","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"B40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.25259\/sni_239_2022","article-title":"Tumefactive multiple sclerosis versus high grade glioma: a diagnostic dilemma","volume":"13","author":"French","year":"2022","journal-title":"Surg Neurol Int"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1552-6569.2007.00231.x","article-title":"Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy","volume":"18","author":"Zacharia","year":"2008","journal-title":"J Neuroimaging"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2010.01.017","article-title":"Parenchymal lymphoma of the brain on initial MR imaging: a comparative study between primary and secondary brain lymphoma","volume":"79","author":"Senocak","year":"2011","journal-title":"Eur J Radiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ejrad.2005.12.032","article-title":"Perfusion and diffusion MR imaging in enhancing Malignant cerebral tumors","volume":"58","author":"Calli","year":"2006","journal-title":"Eur J Radiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-006-0123-y","article-title":"Analysis of the utility of diffusion-weighted MRI and apparent diffusion coefficient values in distinguishing central nervous system toxoplasmosis from lymphoma","volume":"48","author":"Schroeder","year":"2006","journal-title":"Neuroradiology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.35.360","article-title":"Recurrent primary central nervous system lymphoma mimicking neurodegenerative disease--an autopsy case report","volume":"35","author":"Matsumoto","year":"1995","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2013.83","article-title":"Diagnosis and treatment of primary CNS lymphoma","volume":"9","author":"Korfel","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.986473","article-title":"Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma","volume":"13","author":"Sun","year":"2022","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/neup.12276","article-title":"Primary central nervous system lymphomas and related diseases: Pathological characteristics and discussion of the differential diagnosis","volume":"36","author":"Sugita","year":"2016","journal-title":"Neuropathology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-009-0178-z","article-title":"The pathological spectrum of CNS inflammatory demyelinating diseases","volume":"31","author":"Hu","year":"2009","journal-title":"Semin Immunopathol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s10014-021-00408-z","article-title":"Primary central nervous system lymphoma: clinicopathological and genomic insights for therapeutic development","volume":"38","author":"Tateishi","year":"2021","journal-title":"Brain Tumor Pathol"},{"key":"B51","article-title":"Tumefactive multiple sclerosis presenting as acute ischemic stroke","volume":"4","author":"Yacoub","year":"2011","journal-title":"J Vasc Interv Neurol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/bf03167070","article-title":"Serum IL-10 and IL-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin's lymphoma","volume":"60","author":"el-Far","year":"2004","journal-title":"J Physiol Biochem"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nor203","article-title":"Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL)","volume":"14","author":"Sasayama","year":"2012","journal-title":"Neuro Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380212","article-title":"Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications","volume":"38","author":"Balmaceda","year":"1995","journal-title":"Ann Neurol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000326958.52546.f5","article-title":"Meningeal dissemination in primary CNS lymphoma: prospective evaluation of 282 patients","volume":"71","author":"Fischer","year":"2008","journal-title":"Neurology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nop053","article-title":"Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohort","volume":"12","author":"Kiewe","year":"2010","journal-title":"Neuro Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1763680\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:16:52Z","timestamp":1780039012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1763680\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":56,"alternative-id":["10.3389\/fonc.2026.1763680"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1763680","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1763680"}}